Skip to main content
. 2014 Mar 31;6:37–45. doi: 10.2147/DHPS.S43304

Figure 3.

Figure 3

SVR12 rates in treatment-experienced patients with and without cirrhosis: FUSION study results.

Notes: Comparison of SVR12 in treatment-experienced patients with chronic HCV genotype 2 or 3 receiving SOF + RBV for either 12 weeks or 16 weeks.29

Abbreviations: G2, HCV genotype 2; G3, HCV genotype 3; HCV, hepatitis C virus; RBV, ribavirin; SOF, sofosbuvir; SVR12, sustained virologic response rate 12 weeks after treatment.